Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · see citing works

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063 · see citing works

Malignant Gliomas in Adults

Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 4,201 · see citing works

Human cytomegalovirus infection and expression in human malignant glioma.

Cobbs, C., Harkins, L. E., Samanta, M., Gillespie, G. Y., Bharara, S., King, P. H., Nabors, B., Cobbs, C. G., & Britt, W. J. (2002) · PubMed · Cited by 705 · see citing works

Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors

Söderberg‐Nauclér, C., Fish, K. N., & Nelson, J. A. (1997) · Cell · doi:10.1016/s0092-8674(01)80014-3 · Cited by 699 · see citing works

Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)

Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., & Pestka, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1695 · Cited by 519 · see citing works

CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease: CD8+ CD28− (CD8+ CD57+) T cells in health and disease

Strioga, M., Pasukoniene, V., & Characiejus, D. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03470.x · Cited by 505 · see citing works

Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines

Saurwein-Teissl, M., Lung, T. L., Marx, F., Gschösser, C., Asch, E., Blasko, I., Parson, W., Böck, G., Schönitzer, D., Trannoy, E., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5893 · Cited by 499 · see citing works

CD28 extinction in human T cells: altered functions and the program of T‐cell senescence

Vallejo, A. N. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00256.x · Cited by 435 · see citing works

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

Mitchell, D. A., Xie, W., Schmittling, R. J., Learn, C. A., Friedman, A. H., McLendon, R. E., & Sampson, J. H. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-035 · Cited by 390 · see citing works

Emergence of a CD4+CD28− Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection

van Leeuwen, E. M. M., Remmerswaal, E. B. M., Vossen, M. T. M., Rowshani, A. T., Dillen, P. M. E. W., van Lier, R. A. W., & ten Berge, I. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1834 · Cited by 369 · see citing works

Implication of γδ T cells in the human immune response to cytomegalovirus

Déchanet‐Merville, J., Merville, P., Lim, A., Retière, C., Pitard, V., Lafarge, X., Michelson, S., Méric, C., Hallet, M., Kourilsky, P., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5409 · Cited by 338 · see citing works

Immune defects observed in patients with primary malignant brain tumors

Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323 · see citing works

T Cell Replicative Senescence in Human Aging

P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323 · see citing works

Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10

Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T., & Schall, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1285-1292.2002 · Cited by 322 · see citing works

Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease

Nielsen, C. M., White, M. J., Goodier, M. R., & Riley, E. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00422 · Cited by 282 · see citing works

CD57+ T lymphocytes and functional immune deficiency

Focosi, D., Bestagno, M., Burrone, Ó. R., & Petrini, M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809566 · Cited by 253 · see citing works

Human cytomegalovirus: Latency and reactivation in the myeloid lineage

Sinclair, J. H. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.11.014 · Cited by 245 · see citing works

The Cytomegalovirus-Specific CD4 ⁺ T-Cell Response Expands with Age and Markedly Alters the CD4 ⁺ T-Cell Repertoire

Pourgheysari, B., Khan, N., Best, D., Bruton, R., Nayak, L., & Moss, P. A. H. (2007) · Journal of Virology · doi:10.1128/jvi.01262-06 · Cited by 214 · see citing works

When aging reaches CD4+ T-cells: phenotypic and functional changes

Moro‐García, M. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00107 · Cited by 212 · see citing works

Immune evasion by cytomegalovirus—survival strategies of a highly adapted opportunist

Hengel, H. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01255-4 · Cited by 208 · see citing works

Loss of CD28 expression on T lymphocytes: A marker of replicative senescence

Effros, R. B. (1997) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(97)00027-x · Cited by 175 · see citing works

Rapid turnover of the CD8(+)CD28(−) T-cell subset of effector cells in the circulation of patients with head and neck cancer

Tsukishiro, T., Donnenberg, A. D., & Whiteside, T. L. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0395-6 · Cited by 158 · see citing works

Significant Association of Multiple Human Cytomegalovirus Genomic Loci with Glioblastoma Multiforme Samples

Ranganathan, P., Clark, P. A., Kuo, J. S., Salamat, M. S., & Kalejta, R. F. (2011) · Journal of Virology · doi:10.1128/jvi.06097-11 · Cited by 149 · see citing works

Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival

Rahbar, A., Orrego, A., Peredo, I. H., Džabić, M., Wolmer‐Solberg, N., Strååt, K., Stragliotto, G., & Söderberg‐Nauclér, C. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.12.018 · Cited by 142 · see citing works

Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype

Dziurzynski, K., Wei, J., Qiao, W., Hatiboğlu, M. A., Kong, L.-Y., Wu, A., Wang, Y., Cahill, D. P., Levine, N. B., Prabhu, S. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0414 · Cited by 141 · see citing works

CD4+CD28null T cells in coronary artery disease: when helpers become killers

Dumitriu, I. E., Araguás, E. T., BABOONIAN, C., & Kaski, J. C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn248 · Cited by 125 · see citing works

Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

Prins, R. M., Wang, X., Soto, H., Young, E., Lisiero, D. N., Fong, B., Everson, R. G., Yong, W. H., Lai, A., Li, G., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182811ae4 · Cited by 124 · see citing works

Cytomegalovirus Infection in Patients With HIV-1 Infection

Cheung, T., & TEICH, S. A. (2019) · Case Medical Research · doi:10.31525/ct1-nct04067869 · Cited by 111 · see citing works

Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection

van Leeuwen, E. M. M., Remmerswaal, E. B. M., Heemskerk, M. H. M., ten Berge, I. J. M., & van Lier, R. A. W. (2006) · Blood · doi:10.1182/blood-2006-03-006809 · Cited by 106 · see citing works

Implication of gamma-delta T cells in the human immune response to cytomegalovirus

Déchanet, J. (1999) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)90476-6 · Cited by 102 · see citing works

Genetic Analysis of Cytomegalovirus in Malignant Gliomas

Bhattacharjee, B., Renzette, N., & Kowalik, T. F. (2012) · Journal of Virology · doi:10.1128/jvi.00015-12 · Cited by 98 · see citing works

Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

Nair, S. K., Leon, G. D., Boczkowski, D., Schmittling, R. J., Xie, W., Staats, J. S., Liu, R., Johnson, L. A., Weinhold, K. J., Archer, G. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3268 · Cited by 93 · see citing works

Exclusive increase of CX3CR1+CD28−CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes

Kobayashi, T., Okamoto, S., Iwakami, Y., Nakazawa, A., Hisamatsu, T., Chinen, H., Kamada, N., Imai, T., Goto, H., & Hibi∥, T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20113 · Cited by 85 · see citing works

Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma

Bryant, N. L., Suarez‐Cuervo, C., Gillespie, G. Y., Markert, J. M., Nabors, B., Meleth, S., Lopez, R. D., & Lamb, L. S. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-111 · Cited by 81 · see citing works

Skewed distribution of proinflammatory CD4+CD28nullT cells in rheumatoid arthritis

Fasth, A. E. R., Snir, O., Johansson, A. A., Nordmark, B., Rahbar, A., af Klint, E., Björkström, N. K., Ulfgren, A., van Vollenhoven, R., Malmström, V., et al. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2286 · Cited by 80 · see citing works

Expanded T cell receptor Vβ–restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells

Pandya, J. M., Fasth, A. E. R., Zong, M., Arnardottir, S., Dani, L., Lindroos, E., Malmström, V., & Lundberg, I. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27665 · Cited by 76 · see citing works

Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection

van den Berg, A. P., KLOMPMAKER, I. J., Haagsma, E. B., Peeters, P. M. J. G., Meerman, L., Verwer, R., THE, T. H., & Sloof, M. J. H. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00433.x · Cited by 67 · see citing works

γ/δ T cell subsets in human aging using the classical α/β T cell model

Vasudev, A., Ying, C., Ayyadhury, S., Puan, K. J., Andiappan, A. K., Nyunt, M. S. Z., Shadan, N. B., Mustafa, S., Low, I., Rötzschke, O., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a1213-650rr · Cited by 63 · see citing works

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

Bryant, N. L., Gillespie, G. Y., Lopez, R. D., Markert, J. M., Cloud, G. A., Langford, C. P., Arnouk, H., Su, Y. Y., Haines, H. L., Suarez‐Cuervo, C., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0245-2 · Cited by 60 · see citing works

Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors

Morford, L. A., Dix, A. R., Brooks, W. H., & Roszman, T. L. (1999) · Journal of neurosurgery · doi:10.3171/jns.1999.91.6.0935 · Cited by 52 · see citing works

A killer on the road: circulating CD4+CD28null T cells as cardiovascular risk factor in ESRD patients

Betjes, M. G. H., Meijers, R. W. J., de Wit, L. E. A., & Litjens, N. H. R. (2011) · Journal of Nephrology · doi:10.5301/jn.5000057 · Cited by 43 · see citing works

Imbalances in T cell subpopulations in human gliomas

Bhondeley, M. K., Mehra, R. D., Mehra, N., Mohapatra, A. K., Tandon, P. N., Roy, S., & Bijlani, V. (1988) · Journal of neurosurgery · doi:10.3171/jns.1988.68.4.0589 · Cited by 43 · see citing works

Human Cytomegalovirus Manipulation of Latently Infected Cells

Sinclair, J. H., & Reeves, M. B. (2013) · Viruses · doi:10.3390/v5112803 · Cited by 38 · see citing works

The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections.

Wang, E. C. Y., & Borysiewicz, L. K. (1995) · PubMed · Cited by 37 · see citing works

Discordant humoral and cellular immune responses toCytomegalovirus(CMV) in glioblastoma patients whose tumors are positive for CMV

Rahbar, A., Peredo, I. H., Wolmer‐Solberg, N., Taher, C., Džabić, M., Xu, X., Skarman, P., Fornara, O., Tammik, C., Yaiw, K.-C., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.982391 · Cited by 34 · see citing works

Gene expression and generation of CD28−CD8 T cells mediated by interleukin 15

Godlove, J. M., CHIU, W., & Weng, N. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.11.015 · Cited by 28 · see citing works

Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy

Márquez-Medina, D., Fortuny, J. S., & Salud, A. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0935-7 · Cited by 27 · see citing works

CD4+CD28null cells are an independent predictor of mortality in patients with heart failure

Koller, L., Richter, B., Goliasch, G., Blum, S., Korpak, M., Zorn, G., Brekalo, M., Maurer, G., Wojta, J., Pacher, R., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.008 · Cited by 25 · see citing works

Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation

Peggs, K. S., & Mackinnon, S. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.008 · Cited by 18 · see citing works

Novel approaches and mechanisms of immunotherapy for glioblastoma.

Hegde, M. G., Bielamowicz, K., & Ahmed, N. M. (2014) · PubMed · Cited by 17 · see citing works

Profile of immune cells in lymph nodes draining human malignant tumors.

Girolamo, W. D., Coronato, S., Portiansky, E. L., & Laguens, G. (2008) · PubMed · Cited by 15 · see citing works

Comparison of Petrifilm Staph Express Count System with the Bacteriological Analytical Manual Direct-Plating Method for Enumeration of Staphylococcus aureus in Artificially Contaminated Hard Cheese

Fedio, W. M., Wendakoon, C. N., Zapata, R., Carrillo, C., & Browning, P. (2008) · Journal of AOAC International · doi:10.1093/jaoac/91.5.1138 · Cited by 7 · see citing works

Immunosenescence: a key player in cancer development

Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00986-z · Cited by 510 · see citing works

T-cell Dysfunction in Glioblastoma: Applying a New Framework

Woroniecka, K. I., Rhodin, K. E., Chongsathidkiet, P., Keith, K. A., & Fecci, P. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0047 · Cited by 316 · see citing works

Immune suppression in gliomas

Grabowski, M. M., Sankey, E. W., Ryan, K. J., Chongsathidkiet, P., Lorrey, S., Wilkinson, D. S., & Fecci, P. E. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03483-y · Cited by 270 · see citing works

CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Hoyt-Miggelbrink, A. M., Jackson, J. D., Lorrey, S., Srinivasan, E. S., Polania, J. W., Wilkinson, D. S., & Fecci, P. E. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0206 · Cited by 239 · see citing works

The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology

Huff, W. X., Kwon, J. H., Henriquez, M., Fetcko, K., & Dey, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112810 · Cited by 217 · see citing works

Senescent T cells: a potential biomarker and target for cancer therapy

Zhang, J., He, T., Xue, L., & Guo, H. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103409 · Cited by 171 · see citing works

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes

Mohme, M., Schliffke, S., Maire, C. L., Rünger, A., Glau, L., Mende, K. C., Matschke, J., Gehbauer, C., Akyüz, N., Zapf, S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2617 · Cited by 152 · see citing works

The Biology of Aging and Cancer

Zhang, X., Meng, X., Chen, Y., Leng, S. X., & Zhang, H. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000270 · Cited by 105 · see citing works

Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them

Habashy, K. J., Mansour, R., Moussalem, C., Sawaya, R., & Massaad, M. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01864-w · Cited by 95 · see citing works

Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease

Müller, L., & Benedetto, S. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020753 · Cited by 82 · see citing works

The Biology of Aging and Cancer: Frailty, Inflammation, and Immunity

Zhang, X., Meng, X., Chen, Y., Leng, S. X., & Zhang, H. (2017) · The Cancer Journal · doi:10.1097/00130404-201707000-00002 · Cited by 78 · see citing works

Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?

Turner, J. E., & Brum, P. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4234765 · Cited by 65 · see citing works

Oncolytic Viruses for Malignant Glioma: On the Verge of Success?

Suryawanshi, Y. R., & Schulze, A. J. (2021) · Viruses · doi:10.3390/v13071294 · Cited by 56 · see citing works

Tumor-Specific T Cell Activation in Malignant Brain Tumors

Mohme, M., & Neidert, M. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00205 · Cited by 54 · see citing works

Cytomegalovirus driven immunosenescence—An immune phenotype with or without clinical impact?

Söderberg‐Nauclér, C., Fornara, O., & Rahbar, A. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.06.005 · Cited by 30 · see citing works

The impact of inflationary cytomegalovirus‐specific memory T cells on anti‐tumour immune responses in patients with cancer

Luo, X., Meng, Q., Rao, M., Liu, Z., Paraschoudi, G., Dodoo, E., & Maeurer, M. J. (2018) · Immunology · doi:10.1111/imm.12991 · Cited by 32 · see citing works

T-cell Senescence in the Tumor Microenvironment

Huang, L., Zhang, C., Jiang, A., Lin, A., Zhu, L., Mou, W., Zeng, D., Liu, Z., Tang, B., Zhang, J., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0894 · Cited by 27 · see citing works

T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies

Saavedra, D., Verdecia, B. G., & Lage, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00146 · Cited by 26 · see citing works

A closer look at the role of iron in glioblastoma

Shenoy, G., & Connor, J. R. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad136 · Cited by 22 · see citing works

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

Sorkhabi, A. D., Sarkesh, A., Saeedi, H., Marofi, F., Ghaebi, M., Silvestris, N., Baradaran, B., & Brunetti, O. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.818447 · Cited by 21 · see citing works

Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients

Coleman, M. J., Zimmerly, K. M., & Yang, X. O. (2021) · Biomolecules · doi:10.3390/biom11101425 · Cited by 20 · see citing works

T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression

Losurdo, A., Muzio, A. D., Cianciotti, B. C., Dipasquale, A., Persico, P., Barigazzi, C., Bono, B., Feno, S., Pessina, F., Santoro, A., et al. (2024) · Cancers · doi:10.3390/cancers16030603 · Cited by 16 · see citing works

Unravelling the mosaic: Epigenetic diversity in glioblastoma

Lucchini, S., Constantinou, M., & Marino, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13706 · Cited by 17 · see citing works

Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes

Rosso, D. A., Rosato, M., Iturrizaga, J., González, N., Shiromizu, C. M., Keitelman, I. A., Coronel, J. V., Gómez, F. D., Amaral, M. M., Rabadán, A. T., et al. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03787-7 · Cited by 16 · see citing works

The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment

Dusoswa, S. A., Verhoeff, J., van Asten, S. D., Lübbers, J., van den Braber, M., Peters, S., Abeln, S., Crommentuijn, M. H. W., Wesseling, P., Vandertop, W. P., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343484 · Cited by 15 · see citing works

Senescent T Cells in Age-Related Diseases

Yu, P.-J., Zhou, M. L., Liu, Y., & Du, J. (2024) · Aging and Disease · doi:10.14336/ad.2024.0219 · Cited by 15 · see citing works

Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy

Britsch, I., van Wijngaarden, A. P., & Helfrich, W. (2023) · Cancers · doi:10.3390/cancers15153767 · Cited by 13 · see citing works

Is Chronic Exposure to Low-Dose Organochlorine Pesticides a New Risk Factor of T-cell Immunosenescence?

Ryu, D.-H., Yu, H. T., Kim, S.-A., Lee, Y., Hong, S.-H., Yoon, Y.-R., Kim, D. J., Kim, H. C., Moon, H., Shin, E., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0799 · Cited by 13 · see citing works

The Role of Senescence, its Therapeutic Relevance and Clinical Implications in the Tumor Microenvironment

Shi, H., Xiao, M., Li, Y., Liu, X., Na, J., Liang, C., Hua, J., Meng, Q., Wei, M., Wang, W., et al. (2025) · Theranostics · doi:10.7150/thno.112633 · Cited by 12 · see citing works

The Role of Gut Microbiome on Glioblastoma Oncogenesis and Malignant Evolution

Mohamed, Z. S., Wu, Q., Jacome, M. A., Chen, J., & Etame, A. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072935 · Cited by 12 · see citing works

Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic Innovations

Liu, J. H., Horiachok, M., Guru, S., & Maire, C. L. (2025) · Brain Sciences · doi:10.3390/brainsci15080833 · Cited by 11 · see citing works

The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies

Wang, L., Luo, Y., Chen, X., Wang, Y., & Zhang, Y. (2025) · MedComm – Oncology · doi:10.1002/mog2.70041 · Cited by 8 · see citing works

Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression

Tritz, Z. P., Ayasoufi, K., Wolf, D. M., Owens, C. A., Malo, C. S., Himes, B. T., Fain, C. E., Goddery, E. N., Yokanovich, L. T., Jin, F., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0570 · Cited by 7 · see citing works

Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease

Rosichini, M., Baldo, G. D., Luca, C. D. D., Benini, F., Genah, S., Vinci, M., Cerimele, A., Coccetti, M., Flamini, S., Carsetti, R., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00755-y · Cited by 6 · see citing works

Cytomegalovirus at the crossroads of immunosenescence and oncogenesis

Bouezzedine, F., Baba, R. E., Morot-Bizot, S., Diab‐Assaf, M., & Herbein, G. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00086 · Cited by 6 · see citing works

Is There a Role for Immunotherapy in Central Nervous System Cancers?

Flores, C., Dunn, G. P., Fecci, P. E., Lim, M. K., Mitchell, D. A., & Reardon, D. A. (2021) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2021.09.002 · Cited by 6 · see citing works

Characteristics and postoperative dynamic changes in circulating CD4+ helper T lymphocytes in patients with breast cancer

Lu, Y., Zhang, Q., Wang, J., & Zhang, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1118346 · Cited by 6 · see citing works

Cellular Components of the Tumor Environment in Gliomas—What Do We Know Today?

Nafe, R., & Hattingen, E. (2023) · Biomedicines · doi:10.3390/biomedicines12010014 · Cited by 4 · see citing works

Immunosenescence and Cancer Immunotherapy at Old Age: Basics

Fülöp, T., Witkowski, J. M., Hirokawa, K., Larbi, A., & Pawelec, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-44870-1_77-1 · Cited by 4 · see citing works

Immunosenescence and Cancer Immunotherapy at Old Age: Basics

Fülöp, T., Witkowski, J. M., Hirokawa, K., Larbi, A., & Pawelec, G. (2020) · Springer eBooks · doi:10.1007/978-3-319-57415-8_77 · Cited by 4 · see citing works

CD57-Expressing Lymphocytes: From Chronic Viral Response to Age-Related Inflammation

Vallejo-Bermúdez, I. M., Miranda-Echagüe, M. R., Fernández-Álvarez, S., Reina-Alfonso, I., Blanca-Pariente, L., Batista-Duharte, A., & Pera, A. (2026) · Cells · doi:10.3390/cells15050403 · Cited by 2 · see citing works

Mechanisms of immune suppression in glioblastoma

Ellsworth, S. G., & Grossman, S. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819755-4.00016-3 · Cited by 1 · see citing works

Targeted local combination therapy with checkpoint inhibitors and CAR-NK cells in glioblastoma using DARPin-linked AAV vectors

Strecker, M. (2022) · doi:10.21248/gups.68021

Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma

Tur-Planells, V., Bykov, Y., Dawodu, G. O., Garcia‐Romero, N., Izpura-Luis, S., Pérez‐Rodríguez, L., Rius‐Rocabert, S., Palacín-Aliana, I., Arranz-Herrero, J., Márquez-Leiva, I., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011741

CD163 Dominance Within Macrophages/Microglia Reflects a Favorable Prognosis in Patients With Glioblastoma

Moritsubo, M., Furuta, T., Hashimoto, A., Yoshitake, H., Negoto, T., Nakamura, H., Morioka, M., & Miyoshi, H. (2026) · Neuropathology · doi:10.1111/neup.70071

Senescent T cell population in Glioblastoma

Song, L., Henriquez, M. A., Chintala, S., & Dey, M. (2018) · Proceedings of IMPRS · doi:10.18060/22792

IMMU-06. REDUCTION OF CD4+ T CELLS NEGATIVELY AFFECTS SURVIVAL IN OLD BUT NOT YOUNG MICE WITH GLIOBLASTOMA

Zhai, L., Bell, A., Lauing, K. L., Bommi, P. V., Ladomersky, E., Mi, X., Kocherginski, M., Chandler, J. P., Horbinski, C., Heimberger, A. B., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac209.504

Characteristics of Human Cytomegalovirus specific T-Cells in Glioblastoma Multiforme

Alexander, H. (2015) · The University of Queensland · doi:10.14264/uql.2015.735

CD4+ T cell lymphopenia decreases survival in older adults with glioblastoma

Zhai, L., Penco-Campillo, M., Lauing, K. L., & Wainwright, D. A. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.212.supp.0449.4302

Aging- and Tumor-Mediated Increase in CD8+CD28− T Cells Might Impose a Strong Barrier to Success of Immunotherapy in Glioblastoma

Huff, W. X., Bam, M., Shireman, J. M., Kwon, J. H., Song, L., Newman, S., Cohen‐Gadol, A., Shapiro, S., Jones, T., Fulton, K., et al. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100008 · Cited by 28 · see citing works